Michelle Iocolano

Papers

Total Citations

H-Index

About

Dr. Michelle Iocolano is a radiation oncologist whose research focuses on improving the safety and precision of prostate cancer radiotherapy, particularly for complex patient populations. Her most cited work, "Prostate Fiducial Marker Placement in Patients on Anticoagulation: Feasibility Prior to Prostate SBRT," addresses a critical clinical challenge: performing necessary fiducial marker placement for stereotactic body radiotherapy (SBRT) and image-guided radiation therapy (IGRT) in patients who require continued antiplatelet or anticoagulant therapy. This study demonstrated the feasibility and safety of the procedure in this high-risk group, providing crucial guidance for clinicians managing patients with competing comorbidities. With 7 citations, this work has informed practice patterns and expanded treatment access. Dr. Iocolano’s contributions sit at the intersection of radiation oncology, interventional technique, and patient safety, offering practical solutions that directly impact treatment planning and delivery. Her research underscores a commitment to evidence-based, patient-centered care, making her a valuable voice in the ongoing effort to refine prostate cancer treatment protocols for medically complex individuals.